Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06124079 · ClinicalTrials.gov registry record · NA

The Implementation of a Post-operative Communication App to Improve Pain Control and Opioid Use

A NA study of Acute Pain, sponsored by University of Minnesota.

Recruiting
Registry status
NA
Development phase
3,500
Enrollment target
1
Study location

NCT06124079: Recruiting NA study of Acute Pain, sponsored by University of Minnesota.

NCT06124079 is a NA study of Acute Pain that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 3,500 participants, above the 198-participant average among 50 other Acute Pain trials with a reported enrollment target (1668% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06124079, a NA study of Acute Pain, is actively recruiting participants, sponsored by University of Minnesota.

RECRUITING
Registry status
NA
Development phase
3,500 participants
Enrollment target
1
Study location

Study Summary

Digital communication tools are becoming ubiquitous in healthcare, though their impact on patient/provider communication, healthcare utilization, and outcomes remains poorly established. M Health Fairview (MHFV) in collaboration with the Center for Learning Health System Sciences (CLHSS) Rapid Eval team will be evaluating one such communication application: OPY, which leverages the Epic-Care Companion functionality to remove barriers in communicating with the patient's care team. This project will evaluate the effectiveness of a digital, post-operative patient engagement tool (Epic-Care Companion made available through MyChart), OPY, which has the goal of preventing patients from becoming addicted to opioids or to suffer from opioid misuse or diversion. In the proposed pragmatic trial, standard care with education available in MyChart and the patient after visit summary will be augmented by OPY. OPY is available to patients starting the same day they go home from surgery with a new opioid prescription. OPY provides a daily interactive experience that collects patient pain and side-effect information, provides advice for pain management, and uses behavioral "nudges" to encourage timely weaning and responsible disposal of opioid medications. The primary goal of this project is to evaluate the effect of two versions of OPY on measures of opiate use relative to the standard of care in a pragmatic randomized controlled trial.

Primary Outcome

Opiate use at 14 days is defined as any active opioid script on day 14 post surgery. This information will be collected from the electronic health record.

Conditions Studied

Interventions

  • OTHER Standard care
  • OTHER OPY interactive messaging service

Study Locations (1)

Minnesota

  • University of Minnesota - Minneapolis

Trial Details

FieldValue
Enrollment Target 3,500 participants
Start Date 2024-07-17
Est. Completion 2026-07-17
Phase NA
University of Minnesota

966 total trials

What NCT06124079 shows while recruiting

NCT06124079 is an interventional study that assigns participants to a tested intervention. Its 3,500 participants enrollment target places it among the larger protocols in the corpus, above the 198-participant average among 50 other Acute Pain trials with a reported enrollment target (1668% higher).

The record links to 1 condition, with Acute Pain appearing as the primary indexed condition, and to 2 interventions - of which Standard care is the first listed.

NCT06124079 reports a single indexed study location in Minnesota.

Frequently Asked Questions

What is clinical trial NCT06124079 about?

NCT06124079 is a clinical study titled "The Implementation of a Post-operative Communication App to Improve Pain Control and Opioid Use". Digital communication tools are becoming ubiquitous in healthcare, though their impact on patient/provider communication, healthcare utilization, and outcomes remains poorly established. M Health Fairview (MHFV) in collaboration with the Center for Learning Health System Sciences (CLHSS) Rapid Eval ...

What is the current status of trial NCT06124079?

This trial is currently recruiting. It is a NA study. The enrollment target is 3,500 participants. The study started on 2024-07-17. Estimated completion is 2026-07-17.

What conditions does trial NCT06124079 study?

This clinical trial studies the following conditions: Acute Pain.

What interventions are being tested in trial NCT06124079?

The interventions under investigation include: Standard care (OTHER), OPY interactive messaging service (OTHER).

Who is sponsoring clinical trial NCT06124079?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06124079 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Acute Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06124079's enrollment target sits among peer trials

3,500 1st of 50 higher than 50 of 50 other Acute Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Acute Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00260559 · 3,500 participants

    Outcomes After Esophagectomy With a Focus on Minimally Invasive Esophagectomy and Quality of Life

  • NCT01612949 · 3,500 participants

    Facial Analysis to Classify Difficult Intubation

  • NCT02398786 · 3,500 participants

    Myotonic Dystrophy Family Registry

  • NCT03486873 · 3,500 participants · Phase 3

    Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06124079, the US trial registry maintained by the National Library of Medicine. NCT06124079 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.